Sepse: Critical Analysis of New Sepse Definitions and Retrospective Evaluation of Sepse Protocol at a Tertiary Hospital in Brazil
NCT03217981 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 506
Last updated 2017-08-04
Summary
Research in the databases Lilacs, BIREME, SciELO by the terms: systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis and septic shock and their equivalents in the English language. Selection of the main articles of the last five years to study and contextualize the reality presented since the implantation of the HUVR sepsis protocol. Statistical analysis of data since the implementation of the sepsis protocol in the HUVR, in July 2014 until June 2016.
Conditions
Interventions
- OTHER
-
Sepsis protocol
Adherence to the sepsis protocol
Sponsors & Collaborators
-
Unimed Volta Redonda
lead OTHER
Principal Investigators
-
Leila Auler · Director
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-02
- Primary Completion
- 2017-08-05
- Completion
- 2017-08-08
Countries
- Brazil
Study Locations
More Related Trials
-
Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
NCT02871895 ·Status: UNKNOWN
-
Sepsis Institutional Registry in Hospital Italiano de Buenos Aires
NCT01403935 ·Status: COMPLETED
-
Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.
NCT04716842 ·Status: UNKNOWN
-
Severe Sepsis and Septic Shock Registry
NCT02936232 ·Status: RECRUITING
-
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
NCT05953142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis
NCT02198950 ·Status: COMPLETED
-
Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis
NCT06219135 ·Status: RECRUITING
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4
-
Triage Score VS Quick-Sofa Score in Septic Patients in the Emergency Department
NCT04913246 ·Status: COMPLETED
-
Predict Sepsis; the Predictive Value of Bedside Measures in the Ambulance
NCT03249597 ·Status: COMPLETED
-
Shock Indices Use for Early Mortality From Septic Shock
NCT05088109 ·Status: UNKNOWN
-
A Prediction Model of 28-day Mortality in Septic Shock
NCT04915625 ·Status: UNKNOWN
-
Derivation and Validation of a Prognostic Model for Septic Patients at Hospital Admission
NCT03601767 ·Status: UNKNOWN
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Cerebrovascular Autoregulation in Sepsis, Influence of Renal Replacement Therapy
NCT01926301 ·Status: WITHDRAWN
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN
-
Registration of Sepsis Patients in the Emergency Department
NCT06068192 ·Status: NOT_YET_RECRUITING
-
Renal Resistive Index in Septic Shock Patients
NCT06214715 ·Status: ACTIVE_NOT_RECRUITING
-
Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis
NCT06657781 ·Status: RECRUITING
-
The Value of Peripheral Arterial Resistive Index in Evaluation of Tissue Perfusion in Patients With Septic Shock
NCT05902273 ·Status: COMPLETED
-
Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions
NCT02820675 ·Status: COMPLETED ·Phase: NA
-
Establishment of Early Diagnosis and Monitoring Model for Sepsis Patients
NCT04974411 ·Status: UNKNOWN
-
Impact of the Introduction of a Performance Improvement Program on the Initial Management of Sepsis and Septic Shock in Adults in the Emergency Department: a Before-and-after Study (IPA-SOS)
NCT06657625 ·Status: ENROLLING_BY_INVITATION
-
We Collected Blood Samples From Septic Shock Patients and Measured ELABELA, Creatinine, and NGAL Levels. Survival After 7 Days Was Recorded and Analyzed to Evaluate the Potential of Serum ELABELA as an Early Diagnostic Marker for Sepsis-associated Acute Kidney Injury.
NCT06001294 ·Status: UNKNOWN
-
Venous to Arterial Carbon Dioxide Difference (P₍ᵥ-ₐ₎CO₂): Predictor of Septic Patient Prognosis Depending on the ScvO₂
NCT03292120 ·Status: COMPLETED ·Phase: NA